D. Biek

发表

Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure

Ronald N. Jones, D. Farrell, J. Le, 2016, The Pediatric infectious disease journal.

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

P. Eckburg, G. Witherell, T. O'Neal, 2012, Antimicrobial Agents and Chemotherapy.

Bacterial Skin and Skin Structure Infections plus Aztreonam in Treatment of Acute Ceftaroline Fosamil versus Vancomycin Response at Day 3 in Two Phase 3 Trials of CANVAS 1 and 2: Analysis of Clinical

T. O'Neal, L. Llorens, D. Biek, 2012 .

Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active In Vitro among β-Lactam Agents

Ronald N. Jones, D. Farrell, H. Sader, 2014, Antimicrobial Agents and Chemotherapy.

Propagation of pSC101 plasmids defective in binding of integration host factor

S. Cohen, D. Biek, 1992, Journal of bacteriology.

Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections

T. Riccobene, G. Udeani, A. Jandourek, 2014, Expert review of clinical pharmacology.

Effect of In Vitro Testing Parameters on Ceftazidime-Avibactam Minimum Inhibitory Concentrations

K. Krause, I. Critchley, D. Biek, 2015, International scholarly research notices.

Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial 2

P. Eckburg, G. Witherell, T. O'Neal, 2012 .

In Vivo Efficacy of Ceftaroline Fosamil in a Methicillin-Resistant Panton-Valentine Leukocidin-Producing Staphylococcus aureus Rabbit Pneumonia Model

F. Vandenesch, G. Lina, P. Charles, 2014, Antimicrobial Agents and Chemotherapy.

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

G. Talbot, D. Sahm, D. Biek, 2008, Antimicrobial Agents and Chemotherapy.

Efficacy of Ceftaroline Fosamil in a Staphylococcal Murine Pneumonia Model

D. Nicolau, J. Crandon, D. Biek, 2012, Antimicrobial Agents and Chemotherapy.

Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009

S. Richter, G. Doern, D. Diekema, 2011, Antimicrobial Agents and Chemotherapy.

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.

Ronald N. Jones, M. Jacobs, R. Mendes, 2014, Diagnostic microbiology and infectious disease.

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.

T. Riccobene, I. Critchley, D. Thye, 2010, The Journal of antimicrobial chemotherapy.

In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae

C. Whitney, L. McGee, K. Klugman, 2008, Antimicrobial Agents and Chemotherapy.

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.

Ronald N. Jones, A. Tsakris, H. Sader, 2012, The Journal of antimicrobial chemotherapy.

Ceftaroline Activity Against Staphylococci and Characterization of S. aureus with Elevated Ceftaroline MIC Values: Results from the Ceftaroline Surveillance Program

H. Sader, I. Critchley, D. Biek, 2009 .

A refined map of the hisG gene of Salmonella typhimurium.

H. Johnston, J. Roth, D. Biek, 1979, Genetics.

Duplications of histidine transport genes in Salmonella typhimurium and their use for the selection of deletion mutants

G. Ames, E. Spudich, D. Biek, 1978, Journal of bacteriology.

Panton-Valentine Leukocidin Is Not the Primary Determinant of Outcome for Staphylococcus aureus Skin Infections: Evaluation from the CANVAS Studies

B. Sharma-Kuinkel, F. Ruffin, V. Fowler, 2012, PloS one.

Review of ceftaroline fosamil microbiology: integrated FOCUS studies.

P. Eckburg, I. Critchley, A. Jandourek, 2011, The Journal of antimicrobial chemotherapy.

Involvement of integration host factor (IHF) in maintenance of plasmid pSC101 in Escherichia coli: mutations in the topA gene allow pSC101 replication in the absence of IHF

S. Cohen, D. Biek, 1989, Journal of bacteriology.

Probing plasmid partition with centromere‐based incompatibility

D. Lane, J. Rech, J. Bouet, 2004, Molecular microbiology.

Involvement of integration host factor (IHF) in maintenance of plasmid pSC101 in Escherichia coli: characterization of pSC101 mutants that replicate in the absence of IHF

S. Cohen, D. Biek, 1989, Journal of bacteriology.

Regulation of Tn5 transposition.

J. Roth, D. Biek, 1981, Cold Spring Harbor symposia on quantitative biology.

Identification and characterization of recD, a gene affecting plasmid maintenance and recombination in Escherichia coli

S. Cohen, D. Biek, 1986, Journal of bacteriology.

Involvement ofIntegration HostFactor (IHF)inMaintenance of Plasmid pSC101inEscherichia coli: Mutations inthetopAGene AllowpSC101Replication intheAbsenceofIHF

Stanley N Cohen, D. Biek, 1989 .

Stable inheritance of bacterial plasmids: practical considerations in the release of organisms into the environment.

S. Cohen, S. Beaucage, C. Miller, 1988, Basic life sciences.

Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.

E. Batard, J. Caillon, G. Potel, 2010, The Journal of antimicrobial chemotherapy.

Antimicrobial Activity of Ceftaroline Tested Against Streptococci from United States (USA) and European (EU) Medical Centers: Results from the Ceftaroline Surveillance Program

Ronald N. Jones, I. Critchley, D. Biek, 2009 .

A single 43-bp sopC repeat of plasmid mini-F is sufficient to allow assembly of a functional nucleoprotein partition complex.

D. Biek, J. Shi, J. Shi, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

E. Batard, J. Caillon, G. Potel, 2011, The Journal of antimicrobial chemotherapy.

Role in Cell Permeability of an Essential Two-Component System in Staphylococcus aureus

Dongxu Sun, M. Schmid, D. Biek, 1999, Journal of bacteriology.

In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime

A. Fenoll, J. Granizo, L. Aguilar, 2008, Antimicrobial Agents and Chemotherapy.

P1 plasmid partition: in vivo evidence for the ParA‐ and ParB‐mediated formation of an anchored parS complex in the absence of a partner parS

M. Yarmolinsky, R. Edgar, D. Biek, 2006, Molecular microbiology.

Partition functions of mini-F affect plasmid DNA topology in Escherichia coli.

D. Biek, J. Strings, 1995, Journal of molecular biology.

The F plasmid centromere, sopC, is required for full repression of the sopAB operon.

P. Yates, D. Lane, D. Biek, 1999, Journal of molecular biology.

Cloning and Functional Characterization of an NAD+-Dependent DNA Ligase from Staphylococcus aureus

M. Mansour, D. Danley, T. Gootz, 2001, Journal of Bacteriology.

Regulation of Tn5 transposition in Salmonella typhimurium.

J. Roth, D. Biek, 1980, Proceedings of the National Academy of Sciences of the United States of America.

High-level expression and secretion of a lysine-containing analog of Escherichia coli heat-stable enterotoxin.

Z. Ping, D. Biek, D. Mann, 1991, Protein expression and purification.

Evaluation of Pneumococci From the United States (USA) Pediatric Patients Isolated During the 2009 AWARE Program

K. Krause, H. Sader, I. Critchley, 2011 .

Ceftaroline versus Ceftriaxone in a Highly Penicillin-Resistant Pneumococcal Pneumonia Rabbit Model Using Simulated Human Dosing

P. Charles, L. Piroth, D. Biek, 2011, Antimicrobial Agents and Chemotherapy.

Evaluation of Ceftaroline Activity versus Ceftriaxone against Clinical Isolates of Streptococcus pneumoniae with Various Susceptibilities to Cephalosporins in an In Vitro Pharmacokinetic/Pharmacodynamic Model

M. Rybak, C. Vidaillac, D. Biek, 2012, Antimicrobial Agents and Chemotherapy.

Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States

Ronald N. Jones, Michael R. Jacobs, Helio S. Sader, 2010, Antimicrobial Agents and Chemotherapy.

In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcusaureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcusfaecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin

E. Batard, J. Caillon, G. Potel, 2009, Antimicrobial Agents and Chemotherapy.

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model.

E. Batard, J. Caillon, G. Potel, 2010, The Journal of antimicrobial chemotherapy.

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012

K. Krause, I. Critchley, D. Biek, 2017, Infectious Diseases and Therapy.

A versatile low-copy-number cloning vector derived from plasmid F.

D. Biek, J. Shi, 1995, Gene.

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens

R. Panchal, D. Biek, Stephanie A. Halasohoris, 2021, The Journal of Antibiotics.

ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.

I. Morrissey, D. Biek, R. Janes, 2009, The Journal of antimicrobial chemotherapy.

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

G. Talbot, D. Sahm, D. Biek, 2008, Antimicrobial Agents and Chemotherapy.